Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jan 18, 2022 3:56pm
750 Views
Post# 34330183

RE:Are the counters correct? If so, WOW

RE:Are the counters correct? If so, WOW

cashascars wrote: I've never seen anywhere on Stockhouse the amount of reads showing on TLT Bullboard. If the counter is displaying correctly, the amount of interest in this company is beyond any other that came before it. 700 or more reads is not uncommon today.
When the interest turns into investors we will see huge gains, bringing this company to a Market Cap it deserves. With a 2 treatment process to cure Bladder cancer and no serious discomfort or side affects, with many more potential cancer targets to come. My thoughts of a proper Market Cap is Much Much higher than present, all we need is more positive results from our phase 2 and in my optomistic view they are on thier way shortly so don't miss out on the move up into the dollars, now is the time to strike or pay more later. 
Again I'm a little over the top some times with my opinions but correct me if I'm way out please.
cashascars

 

cashascars...for a car salesman, you're actually on point ; ).  By offering a better ACT option for a finite number of cancers (the superficial/accessible tumors), the MC would certainly be in the tens of billions.  An even bigger goldmine imo needs to be unleashed in the form effective/efficient treatment of interstitial or deep-seated cancers (I.e. via x-ray activation).  This is where a Pharma partnership could expedite our path to unlimited wealth.  You can forget about what I said in my last post re: a partnership with McFarland's private company...I'm getting old/less healthy & my money timeline is quickly shortening!

<< Previous
Bullboard Posts
Next >>